Hanafusa Y, Inoue K, Ozawa A, Sekiguchi S, Ando S, Honda S, Yamada M, Takaba T
First Department of Surgery, Showa University School of Medicine, Tokyo, Japan.
Nihon Kyobu Geka Gakkai Zasshi. 1997 Apr;45(4):536-42.
Isolated rat hearts were subjected to 30 min global ischemia followed 20 min reperfusion with various concentration of Mg2+ Krebs-Henseleit-bicarbonate buffer (KHB buffer) (Mg2+:1.2 mM, 2.5 mM, 5 mM, 10 mM) and 20 min reperfusion with original KHB buffer (Mg2+:1.2 mM) at 37 degrees C, respectively. Cardiac function and the incidence of ventricular arrhythmia were measured during pre-ischemia and reperfusion, and intracellular Ca2+ concentration was measured during pre-ischemia, ischemia and reperfusion period. The hearts reperfused with 1.2 mM Mg2+ presented a significantly higher frequency of ventricular fibrillation (VF) and ventricular tachycardia (VT) than the other groups. Percent recoveries of LVDP (Left ventricular developed pressure) at the Mg2+ concentration of 1.2, 2.5, 5, 10 mM after 40 min reperfusion were 64.3 +/- 5.7%, 108.4 +/- 6.1%, 100.4 +/- 6.1%, 101.5 +/- 5.5%, respectively. Intracellular Ca2+ concentration of the hearts with Mg2+ 1.2 mM revealed 248.9 +/- 15.6% at reperfusion, and that the other groups did not increased during reperfusion. These data suggest that extracellular Mg2+ inhibits reperfusion arrhythmia and Ca2+ overload during reperfusion, and improves cardiac function of reperfused heart.
将离体大鼠心脏进行30分钟全心缺血,随后分别在37℃下用不同浓度的Mg2+ Krebs-Henseleit-碳酸氢盐缓冲液(KHB缓冲液)(Mg2+浓度为1.2 mM、2.5 mM、5 mM、10 mM)进行20分钟再灌注,以及用原始KHB缓冲液(Mg2+浓度为1.2 mM)进行20分钟再灌注。在缺血前和再灌注期间测量心脏功能和室性心律失常的发生率,并在缺血前、缺血和再灌注期间测量细胞内Ca2+浓度。用1.2 mM Mg2+再灌注的心脏出现心室颤动(VF)和室性心动过速(VT)的频率明显高于其他组。再灌注40分钟后,Mg2+浓度为1.2、2.5、5、10 mM时左心室舒张末压(LVDP)的恢复百分比分别为64.3±5.7%、108.4±6.1%、100.4±6.1%、101.5±5.5%。Mg2+浓度为1.2 mM的心脏在再灌注时细胞内Ca2+浓度显示为248.9±15.6%?,而其他组在再灌注期间没有升高。这些数据表明,细胞外Mg2+可抑制再灌注期间的再灌注心律失常和Ca2+超载,并改善再灌注心脏的心脏功能。 ?注:原文中“248.9 +/- 15.6% at reperfusion”这里表述不太清晰,翻译时保留疑问标记 。